PROXY FORM
2020 ANNUAL GENERAL MEETING ARGENX SE
IMPORTANT NOTICE: for the annual meeting 2020 argenx uses the e-voting system of ABN AMRO. The company therefore kindly requests all shareholders who wish to vote at the general meeting but cannot/do not wish to attend, to use the proxy/e-voting services of ABN
via HTTPS://WWW.ABNAMRO.SECURITIESVOTING.COM/SHAREHOLDER/
The e-voting system replaces this paper proxy, but the paper proxy may be used if so desired.
The undersigned:
Full (first and last) name: |
|
Address: |
| Postal Code: |
| Place: |
|
Hereinafter referred to as the “Shareholder”,
Acting in his capacity as holder of (number) ordinary shares in the share capital of argenx SE (1) |
Hereby grants proxy to (2):
Full (first and last) name: |
|
Address: |
| Postal Code: |
| Place: |
|
To represent the Shareholder at the 2018 annual shareholders meeting of argenx SE and to speak and vote on behalf of the Shareholder regarding the following agenda items in accordance with the following voting instructions:
(1) If you are a Beneficial Owner (as defined in the meeting convocation) and wish to be represented at the Meeting by means of this proxy, you must provide a written confirmation from your intermediary (as defined in the “Wet Giraal Effectenverkeer”) showing that you were a Beneficial Owner on the Record Date (as defined in the meeting convocation).
(2) If you have no specific preference for a proxy, you do not have to answer this question. In that case the Company will appoint a proxy holder to represent you at the Meeting and who will vote at the Meeting in accordance with your instructions. If you do not give instructions, the proxy will use his own discretion in casting his vote for the proposed resolutions.
argenx SE Willemstraat 5, 4811 AH Breda, The Netherlands
info@argenx.com — www.argenx.com
no. |
| voting item |
| yes |
| no |
| abstain |
3. |
| Adoption of the new remuneration policy |
|
|
|
|
|
|
4. |
| Advisory vote to approve the 2019 remuneration report |
|
|
|
|
|
|
4.b. |
| Adoption of the 2019 annual accounts |
|
|
|
|
|
|
4.d. |
| Allocation of losses of the Company in the financial year 2019 to the retained earnings of the Company |
|
|
|
|
|
|
4.e. |
| Proposal to release the members of the board of directors from liability for their respective duties carried out in the financial year 2019 |
|
|
|
|
|
|
6. |
| Re-appointment of Pamela Klein as non-executive director to the board of directors of the Company |
|
|
|
|
|
|
7. |
| Authorization of the board of directors to grant rights to subscribe for shares in the capital of the Company up to a maximum of 4% of the outstanding capital at the date of the general meeting, pursuant to, and within the limits of, the argenx option plan, for a period of 18 months from the annual general meeting and to limit or exclude statutory pre-emptive rights, if any |
|
|
|
|
|
|
8. |
| Authorization of the board of directors to issue shares and grant rights to subscribe for shares in the share capital of the Company up to a maximum of 10% of the outstanding capital at the date of the general meeting, for a period of 18 months from the annual general meeting and to limit or exclude statutory pre-emptive rights, if an |
|
|
|
|
|
|
9. |
| Authorization of the board of directors to issue additional shares in the share capital of the company up to a maximum of 10% of the outstanding share capital at the date of the general meeting (in addition to the authorizations under 7 and 8), for a period starting on the date of this general meeting and ending on 31 December 2020, for the purpose of a possible public offering of such shares and to limit or exclude statutory pre-emptive rights, if any |
|
|
|
|
|
|
10. |
| Appointment of Deloitte Accountants B.V. as statutory auditor for the 2020 financial year |
|
|
|
|
|
|
I/We instruct my/our proxy as indicated on this form. Unless otherwise instructed the proxy may vote as he or she sees fit or abstain in relation to any business of the meeting.
Signature (3): |
|
| |
|
|
| |
Name: |
|
| |
Date: | / /2020 |
| |
(3) In the case of a corporation, this proxy must be given under its common seal or be signed on its behalf by an attorney or officer duly authorised, stating their capacity (e.g. director, secretary).
argenx SE Willemstraat 5, 4811 AH Breda, The Netherlands
info@argenx.com — www.argenx.com
Please return to: argenx SE, attn General Counsel, p/a Industriepark Zwijnaarde 7, 9052 Zwijnaarde, Belgium
argenx SE Willemstraat 5, 4811 AH Breda, The Netherlands
info@argenx.com — www.argenx.com